GMF Capital

Motorsport Network is a prominent multinational company specializing in multimedia and technology within the automotive and motorsport sectors. It operates a global digital media and technology platform that provides a range of digital assets, including exclusive video content and the largest image library dedicated to motorsports and automotive themes. The company enhances user experiences through its diverse offerings in digital media, gaming, eSports, and event management, making it a significant player in the industry. Its focus on data and statistics further supports its mission to connect enthusiasts and audiences worldwide, providing valuable resources and engagement opportunities within the motorsport community.

sMiles is a platform that facilitates micropayments and micro-incentives using Bitcoin. It employs a gamified approach, allowing users to earn small amounts of Bitcoin by engaging in everyday activities such as walking, shopping, playing games, and participating in surveys. The platform leverages network technology and a backend system designed for micro rewards, providing users with Bitcoin as a reward for their actions and attention. Additionally, it connects location sponsors with users, directing advertising budgets to individuals while fostering customer loyalty. By integrating these elements, sMiles empowers users to earn Bitcoin effortlessly through their daily routines.

Pardes Biosciences is a clinical-stage biopharmaceutical company focused on addressing significant health challenges, particularly those posed by viral infections such as COVID-19. Utilizing modern reversible-covalent chemistry, the company is dedicated to discovering and developing novel oral drug candidates. Its lead product, PBI-0451, is an oral antiviral designed to treat and prevent infections caused by SARS-CoV-2, the virus responsible for COVID-19. Pardes Biosciences aims to enhance patient access to effective treatments, catering to both adult and pediatric populations, while striving to provide convenient and accessible options for those affected by life-threatening viral infections. The company is committed to contributing to global health solutions and improving patient outcomes.

My Sky SA is a company based in Lausanne, Switzerland, specializing in spend management solutions for the aviation industry. Founded in 2016, it serves asset managers, asset owners, and corporate flight departments by providing a platform that automates financial and accounting processes, enhances transparency, and offers independent verification and decision-making services through advanced artificial intelligence. The innovative platform enables jet owners to collect, digitize, verify, analyze, and access vital financial information efficiently. With a team of over 80 experts, including auditors and IT specialists, My Sky adheres to Swiss standards of efficiency, security, and data confidentiality. The company has garnered numerous awards for its contributions to the industry and is committed to revolutionizing jet ownership through technology and expertise. My Sky is expanding its global presence while maintaining its independence, allowing it to remain objective and focused on its mission in the business aviation sector.

InterCure Ltd. is a medical device company that specializes in the development of innovative technologies for the treatment of cardiovascular and pulmonary diseases. Founded in 1994 and based in Hadera, Israel, InterCure has created a patented technology platform known as "Interactive Respiratory-Pacing." This platform has led to the development of product lines that offer non-drug treatments for prevalent conditions such as hypertension and heart failure. The company's flagship product, RESPeRATE, is the only FDA-cleared medical device shown to effectively reduce high blood pressure without side effects. Additionally, InterCure's heart failure treatment, InTone™, has successfully completed phase 2a clinical trials and is awaiting regulatory approval for market launch. With a strong management team and an esteemed Scientific Advisory Board, InterCure aims to lead the market in patient-focused medical devices that address significant health challenges without reliance on pharmaceuticals.

TouchSpin Gaming has created a patented, multiplayer slot platform called TouchSpin Casino. Our first release on the platform is a social casino game called Texas Reels. This is a social, multiplayer slot game for the free to play casual games audience and hybridizes poker and slots. Texas Reels is based on our patented mutliplayer slot mechanic, that let’s you bet against other players sitting with you at the table. All bets go into the pot, like poker, and the winner takes all. TouchSpin Gaming is re-imagining the social casino platform. With revolutionary new slots interfaces, fast and easy game play, powerups and complete meta-game, we’ve created a thrilling new casino game experience, especially for Millienials. The TouchSpin Casino team is managed by technology and gaming professionals who are passionate about creating the next big thing in the casino slot experience. We have put our many years of industry experience into the development of what we believe is the multiplayer casino platform that will redefine the slots category.